Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study

June 28, 2024 updated by: Universitaire Ziekenhuizen KU Leuven

A Comparison of Three Radiotherapy Techniques for Breast Cancer: a Planning Study

This study has the purpose to investigate the benefit of treating breast cancer patients in prone position. This treatment is compared to the standard technique in our center (supine position with or without respiratory gating). The investigators want to compare the doses on the organs at risk (heart and lungs) in the different techniques.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Caroline Sweldens, Doctor
Phone Number: 003216347600
Email: caroline.sweldens@uzleuven.be

Study Locations

Belgium
- - Leuven, Belgium, 3000
    - Recruiting
    - UZ Leuven Radiotherapy Department
    - Contact:
      
      Caroline Sweldens, Doctor
      
      Phone Number: 003216347600
      
      Email: caroline.sweldens@uzleuven.be
    - Sub-Investigator:
      
      Caroline Sweldens, Doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Child
Adult
Older Adult

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

Patients who have an indication for radiotherapy of the breast and/or the lymph nodes.

Description

Inclusion Criteria:

indication for radiotherapy of the breast and /or lymph nodes

Exclusion Criteria:

none ( planning study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitaire Ziekenhuizen KU Leuven

Investigators

Study Director: Caroline Sweldens, Doctor, UZ Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2011

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

January 24, 2011

First Submitted That Met QC Criteria

January 25, 2011

First Posted (Estimated)

January 26, 2011

Study Record Updates

Last Update Posted (Actual)

July 1, 2024

Last Update Submitted That Met QC Criteria

June 28, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

S52869

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.